Kim, J.; Kim, J.-H.; Ko, E.; Kim, J.-Y.; Im, B.S.; Kim, G.H.; Chu, H.H.; Ko, H.-K.; Gwon, D.I.; Shin, J.H.;
et al. Model Predicting Survival in Intermediate-Stage HCC Patients Reclassified for TACE Based on the 2022 BCLC Criteria. Cancers 2025, 17, 894.
https://doi.org/10.3390/cancers17050894
AMA Style
Kim J, Kim J-H, Ko E, Kim J-Y, Im BS, Kim GH, Chu HH, Ko H-K, Gwon DI, Shin JH,
et al. Model Predicting Survival in Intermediate-Stage HCC Patients Reclassified for TACE Based on the 2022 BCLC Criteria. Cancers. 2025; 17(5):894.
https://doi.org/10.3390/cancers17050894
Chicago/Turabian Style
Kim, Jihoon, Jin-Hyoung Kim, Eunbyul Ko, Jeong-Yeon Kim, Byung Soo Im, Gun Ha Kim, Hee Ho Chu, Heung-Kyu Ko, Dong Il Gwon, Ji Hoon Shin,
and et al. 2025. "Model Predicting Survival in Intermediate-Stage HCC Patients Reclassified for TACE Based on the 2022 BCLC Criteria" Cancers 17, no. 5: 894.
https://doi.org/10.3390/cancers17050894
APA Style
Kim, J., Kim, J.-H., Ko, E., Kim, J.-Y., Im, B. S., Kim, G. H., Chu, H. H., Ko, H.-K., Gwon, D. I., Shin, J. H., & Alrashidi, I.
(2025). Model Predicting Survival in Intermediate-Stage HCC Patients Reclassified for TACE Based on the 2022 BCLC Criteria. Cancers, 17(5), 894.
https://doi.org/10.3390/cancers17050894
